These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29945763)

  • 1. Effectiveness of quadrivalent influenza vaccine based on the test-negative control study in children during the 2016-2017 season.
    Ando S
    J Infect Chemother; 2018 Oct; 24(10):782-788. PubMed ID: 29945763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016.
    Sugaya N; Shinjoh M; Nakata Y; Tsunematsu K; Yamaguchi Y; Komiyama O; Takahashi H; Mitamura K; Narabayashi A; Takahashi T;
    Vaccine; 2018 Feb; 36(8):1063-1071. PubMed ID: 29361343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.
    Shinjoh M; Sugaya N; Yamaguchi Y; Iibuchi N; Kamimaki I; Goto A; Kobayashi H; Kobayashi Y; Shibata M; Tamaoka S; Nakata Y; Narabayashi A; Nishida M; Hirano Y; Munenaga T; Morita K; Mitamura K; Takahashi T;
    Vaccine; 2018 Sep; 36(37):5510-5518. PubMed ID: 30093289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
    Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of inactivated quadrivalent influenza vaccine in the 2015/2016 season as assessed in both a test-negative case-control study design and a traditional case-control study design.
    Kimiya T; Shinjoh M; Anzo M; Takahashi H; Sekiguchi S; Sugaya N; Takahashi T
    Eur J Pediatr; 2018 Jul; 177(7):1009-1017. PubMed ID: 29680993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.
    Ando S
    Intern Med; 2020 Apr; 59(7):933-940. PubMed ID: 31787695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Saito N; Komori K; Suzuki M; Morimoto K; Kishikawa T; Yasaka T; Ariyoshi K
    Vaccine; 2017 Jan; 35(4):687-693. PubMed ID: 28043738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usage of quadrivalent influenza vaccine among children in the United States, 2013-14.
    Rodgers L; Pabst LJ; Zhu L; Chaves SS
    Vaccine; 2015 Nov; 33(48):6517-8. PubMed ID: 26296494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico.
    Castillejos M; Cabello-Gutiérrez C; Alberto Choreño-Parra J; Hernández V; Romo J; Hernández-Sánchez F; Martínez D; Hernández A; Jiménez-Álvarez L; Hernández-Cardenas CM; Becerril-Vargas E; Martínez-Orozco JA; Luis Sandoval-Gutiérrez J; Guadarrama C; Olvera-Masetto E; Alfaro-Ramos L; Cruz-Lagunas A; Ramírez G; Márquez E; Pimentel L; Regino-Zamarripa NE; Mendoza-Milla C; Goodina A; Hernández-Montiel E; Barquera R; Santibañez A; Domínguez-Cherit G; Pérez-Padilla R; Regalado J; Santillán-Doherty P; Salas-Hernández J; Zúñiga J
    Int J Infect Dis; 2019 Dec; 89():87-95. PubMed ID: 31493523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccines effectiveness 2013-14 through 2015-16, a test-negative study in children.
    Valdin HL; Bégué RE
    Vaccine; 2017 Jul; 35(33):4088-4093. PubMed ID: 28669621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
    Regan AK; Fielding JE; Chilver MB; Carville KS; Minney-Smith CA; Grant KA; Thomson C; Hahesy T; Deng YM; Stocks N; Sullivan SG
    Vaccine; 2019 May; 37(19):2634-2641. PubMed ID: 30952499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies.
    Young B; Sadarangani S; Jiang L; Wilder-Smith A; Chen MI
    J Infect Dis; 2018 Feb; 217(5):731-741. PubMed ID: 29220496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis.
    Stein Y; Mandelboim M; Sefty H; Pando R; Mendelson E; Shohat T; Glatman-Freedman A;
    Clin Infect Dis; 2018 Apr; 66(9):1383-1391. PubMed ID: 29145568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.